Blood, toxins, cultures, medical use, nes300290 (Harmonized System 1992 for 6-digit)
World Trade (2019): $169B, Rnk 9 / 4648
Top Exporter (2019): $32.6B, Switzerland
Top Importer (2019): $36.9B, United States
Product Complexity (2019): 1.29, Rnk 399 / 4826
Export Growth (CAGR)(2018 - 2019): 8.44%, Rnk 501 / 4648
Mean Tariff (2018): 1.47%, Rnk 6309 / 6538
Share of World Trade (2019): 0.93%, Rnk 9 / 4648
Overview: This page contains the latest trade data of Blood, toxins, cultures, medical use, nes. In 2019, Blood, toxins, cultures, medical use, nes were the world's 9th most traded product, with a total trade of $169B. Between 2018 and 2019 the exports of Blood, toxins, cultures, medical use, nes grew by 8.44%, from $156B to $169B. Trade in Blood, toxins, cultures, medical use, nes represent 0.93% of total world trade.
Exports: In 2019 the top exporters of Blood, toxins, cultures, medical use, nes were Switzerland ($32.6B), Germany ($28.7B), United States ($26.5B), Ireland ($25B), and Belgium ($11B).
Imports: In 2019 the top importers of Blood, toxins, cultures, medical use, nes were United States ($36.9B), Germany ($19.4B), Netherlands ($10B), Switzerland ($9.86B), and Belgium ($9.65B).
Tariffs: In 2018 the average tariff for Blood, toxins, cultures, medical use, nes was 1.47%, making it the 6309th lowest tariff using the HS6 product classification.
The countries with the highest import tariffs for Blood, toxins, cultures, medical use, nes are Ethiopia (13.2%), Romania (8.58%), India (8.18%), Pakistan (7.65%), and Nepal (7.45%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Egypt (0%), Ghana (0%), and Guinea (0%).
Ranking: Blood, toxins, cultures, medical use, nes ranks 399th in the Product Complexity Index (PCI).
Description: Blood is typically used for transfusions. Toxins are used to extract poisons from patients and cultures are used to grow bacteria and fungi. Medical use is typically for diagnostic purposes.
Trade By Country
Top Origin (2019): Switzerland, $32.6B
Top Destination (2019): United States, $36.9B
Blood, toxins, cultures, medical use, nes are the world's 9th most traded product.
In 2019, the top exporters of Blood, toxins, cultures, medical use, nes were Switzerland ($32.6B), Germany ($28.7B), United States ($26.5B), Ireland ($25B), and Belgium ($11B).
In 2019, the top importers of Blood, toxins, cultures, medical use, nes were United States ($36.9B), Germany ($19.4B), Netherlands ($10B), Switzerland ($9.86B), and Belgium ($9.65B).
Trade by country
Top Origin Growth (2018 - 2019): Switzerland, $4.9B
Top Destination Growth (2018 - 2019): United States, $5.45B
Between 2018 and 2019, the exports of Blood, toxins, cultures, medical use, nes grew the fastest in Switzerland ($4.9B), United States ($2.94B), Belgium ($1.44B), Austria ($899M), and Italy ($827M).
Between 2018 and 2019, the fastest growing importers of Blood, toxins, cultures, medical use, nes were United States ($5.45B), China ($2.29B), Germany ($1.92B), Russia ($1.02B), and Japan ($786M).
Cumulative market share
This chart shows the evolution of the market concentration of exports of Blood, toxins, cultures, medical use, nes.
In 2019, market concentration measured using Shannon Entropy, was 3.57. This means that most of the exports of Blood, toxins, cultures, medical use, nes are explained by 11 countries.
TOP NET EXPORTER (2019): Switzerland, $22.7B
TOP NET IMPORTER (2019): United States, $10.4B
This map shows which countries export or import more of Blood, toxins, cultures, medical use, nes. Each country is colored based on the difference in exports and imports of Blood, toxins, cultures, medical use, nes during 2019.
In 2019, the countries that had a largest trade value in exports than in imports of Blood, toxins, cultures, medical use, nes were Switzerland ($22.7B), Ireland ($22B), Germany ($9.35B), Singapore ($2.57B), and Belgium ($1.37B).
In 2019, the countries that had a largest trade value in imports than in exports of Blood, toxins, cultures, medical use, nes were United States ($10.4B), China ($7.19B), Japan ($5.02B), Canada ($4.09B), and France ($3.61B).
In 2018, the average tariff for importing Blood, toxins, cultures, medical use, nes was 1.47%. The countries with the highest tariffs for importing Blood, toxins, cultures, medical use, nes were Ethiopia (13.2%), Romania (8.58%), India (8.18%), Pakistan (7.65%), and Nepal (7.45%).
The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.
Have questions, comments, or concerns?
Send us an e-mail: [email protected]
v4.0.6 ant